Upjohn Inc Business Finance Contracts & Agreements

33 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Viatris Inc. 2020 Stock Incentive Plan
Stock Agreements
Upjohn Inc
Pharmaceuticals
2025
Omnibus Amendment No. 3 to Transaction and Related Agreements among Viatris Inc. and Biocon Biologics Entities
Modification Agreements
Upjohn Inc
Pharmaceuticals
2025
Omnibus Amendment No. 2 to Transaction and Working Capital Agreements among Viatris Inc., Biocon Biologics UK Limited, Biosimilars Newco Limited, and Biocon Biologics Limited
Modification Agreements
Upjohn Inc
Pharmaceuticals
2024
Omnibus Amendment No. 1 to Transaction, Working Capital, and Transition Services Agreements among Viatris Inc., Biocon Biologics UK Limited, Biosimilar Collaborations Ireland...
Modification Agreements
Upjohn Inc
Pharmaceuticals
2023
Amendment No. 1 to Transaction Agreement between Biocon Biologics Limited and Viatris Inc.
Modification Agreements
Upjohn Inc
Pharmaceuticals
NY
2022
Term Loan Credit Agreement among Viatris Inc., Mizuho Bank, Ltd., MUFG Bank, Ltd., and Lenders (July 1, 2021)
Credit Agreements
Upjohn Inc
Pharmaceuticals
NY
2021
Amended and Restated Revolving Credit Agreement among Viatris Inc., Guarantors, and Bank of America, N.A. (as Administrative Agent)
Credit Agreements
Upjohn Inc
Pharmaceuticals
NY
2021
Viatris Inc. Director Restricted Stock Unit Award Agreement
Stock Agreements
Upjohn Inc
Pharmaceuticals
PA
2021
Viatris Inc. Restricted Stock Unit Award Agreement with Participant
Stock Agreements
Upjohn Inc
Pharmaceuticals
PA
2021
Description of Viatris Inc. Common Stock Registered Under Section 12 of the Exchange Act
Stock Agreements
Upjohn Inc
Pharmaceuticals
DE
2021
Amendment No. 4 to Separation and Distribution Agreement between Pfizer Inc. and Upjohn Inc.
Modification Agreements
Upjohn Inc
Pharmaceuticals
2020
Amendment No. 3 to Separation and Distribution Agreement between Pfizer Inc. and Upjohn Inc.
Modification Agreements
Upjohn Inc
Pharmaceuticals
2020
Commercial Paper Dealer Agreement among Viatris Inc., Mylan Inc., Mylan II B.V., Utah Acquisition Sub Inc., and Dealer (2020)
Financing Agreements
Upjohn Inc
Pharmaceuticals
NY
2020
First Supplemental Indenture among Mylan Inc., Utah Acquisition Sub Inc., Mylan II B.V., Viatris Inc., and Citibank, N.A. (Trustee)
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
First Supplemental Indenture among Mylan Inc., Utah Acquisition Sub Inc., Mylan II B.V., Viatris Inc., and The Bank of New York Mellon (Trustee)
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
Fourth Supplemental Indenture among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., and The Bank of New York Mellon (Trustee)
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
Third Supplemental Indenture among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., and The Bank of New York Mellon, dated November 16, 2020
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
First Supplemental Indenture among Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc., Viatris Inc., and Citibank, N.A. (Trustee)
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
First Supplemental Indenture among Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc., Viatris Inc., and The Bank of New York Mellon (Trustee)
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
First Supplemental Indenture among Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc., Viatris Inc., and The Bank of New York Mellon (Trustee)
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
First Supplemental Indenture to 2020 Indenture among Upjohn Finance B.V., Viatris Inc., Mylan Entities, and Citibank, N.A. as Trustee
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
Upjohn Inc. Registration Rights Agreement for Senior Notes (2022–2050) with Initial Purchasers
Registration Rights Agreements
Upjohn Inc
Pharmaceuticals
NY
2020
Delayed Draw Term Loan Credit Agreement among Upjohn Inc. (to be renamed Viatris), MUFG Bank, Ltd., and Lenders, dated June 16, 2020
Credit Agreements
Upjohn Inc
Pharmaceuticals
NY
2020
Revolving Credit Agreement among Upjohn Inc. (to be renamed Viatris), Bank of America, N.A., and Lenders, dated June 16, 2020
Credit Agreements
Upjohn Inc
Pharmaceuticals
NY
2020
Amendment No. 2 to Separation and Distribution Agreement between Pfizer Inc. and Upjohn Inc.
Modification Agreements
Upjohn Inc
Pharmaceuticals
UT
2020
Amendment No. 1 to Separation and Distribution Agreement between Pfizer Inc. and Upjohn Inc.
Modification Agreements
Upjohn Inc
Pharmaceuticals
2020
Description of Viatris Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Upjohn Inc
Pharmaceuticals
DE
2024
Transaction Agreement among Cooper Consumer Health SAS, Cooper Consumer Health IT S.r.l., Viatris Inc., Viatris Italia S.r.l., and Ipex AB (January 29, 2024)
Purchase Agreements
Upjohn Inc
Pharmaceuticals
NY
2024
Transaction Agreement between Biocon Biologics Limited and Viatris Inc. dated February 27, 2022
Purchase Agreements
Upjohn Inc
Pharmaceuticals
DE
2022
Amendment No. 1 to Asset Purchase Agreement between Mylan Ireland Limited and Aspen Global Incorporated
Purchase Agreements
Upjohn Inc
Pharmaceuticals
2021
First Supplemental Indenture to Viatris Inc. Senior Notes Indenture (Guarantee Agreement)
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
Indenture Agreement for Upjohn Finance B.V. Senior Notes Due 2022, 2024, 2027, and 2032 with Citibank, N.A., London Branch as Trustee
Indenture Agreements
Upjohn Inc
Pharmaceuticals
DE
2020
Upjohn Inc. Indenture for $7.45 Billion Senior Notes Due 2022–2050 with The Bank of New York Mellon as Trustee
Indenture Agreements
Upjohn Inc
Pharmaceuticals
NY
2020